MULTAQ is a prescription medicine used to lower the chance you would need to go into the hospital for an irregular heart rhythm called atrial fibrillation (AFib). It is meant for people who have had AFib in the past but are now in normal heart rhythm.
| Droncor Generic |
400mg 60 Tablets |
$194.00 | ||
| Multaq Brand |
400mg 60 Tablets |
$207.00 |
Multaq® (dronedarone) is an antiarrhythmic drug used to reduce the risk of hospital visits in people with a history of certain types of irregular heartbeat (paroxysmal or persistent atrial fibrillation). This drug should not be used by individuals with permanent atrial fibrillation because of an increased risk of serious side effects.
Common Side effects include Diarrhea
Nausea
Vomiting
Pain in the stomach area
Indigestion when you begin taking MULTAQ
Additional side effects may include:
Feeling tired and weak
Skin problems such as redness, rash, and itching
MULTAQ is indicated for the maintenance of sinus rhythm after successful cardioversion in adult
clinically stable patients with paroxysmal or persistent atrial fibrillation (AF).
Due to its safety profile (see sections 4.3 and 4.4), Multaq should only be prescribed after alternative
treatment options have been considered.
MULTAQ should not be given to patients with left ventricular systolic dysfunction or to patients with
current or previous episodes of heart failure.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
Two of the most prevalent disorders in mental health are depression and anxiety. Statistics show that more than one in five of all people in the USA will suffer from either acute anxiety or clinical
Prolia® (generic name: denosumab) is prescribed for patients in danger of developing osteoporosis, usually due to the normal aging process that causes changes in bone density. Osteoporosis was previously thought to be especially prevalent in
By its nature, capturing the “big picture” about a universal health issue, like trends in COVID-19 infection rates, involves collecting, collating, and analyzing a lot of data from many sources. Sometimes, by the time it’s
October is Breast Cancer Awareness month, so what better way than to focus on some recent life-saving treatments? Researchers in Israel are increasingly utilizing Artificial Intelligence to diagnose different types of cancers. Recently, they have
On November 3rd, 2022, an article was published on the front page of the New York Times, reporting on an alarming incidence of prescription drug related deaths across several West African countries. In one single
In the month of May just past, there were a number of exciting new developments in the area of pharmaceutical research announced or released by the Israeli “Start-up Nation” medical research community. Cancer therapies One
Each year the American Society for Bone and Mineral Research (ASBMR) promotes osteoporosis knowledge in the broader community to boost public awareness of a widely prevalent condition for which there are, in fact, some preventative
